Your Health Plan:
Your Health Plan:
Not SelectedNEXLIZET (bempedoic acid and ezetimibe) is a brand-name prescription drug for treatment of Hyperlipoproteinemia Type IIa and Atherosclerotic lesion. NEXLIZET is a combination of adenosine triphosphate-citrate lyase inhibitor and dietary cholesterol absorption inhibitor. It is available in the form of oral tablet.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $435-515.
No other option is found for NEXLIZET